Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Pfizer Inc. (N:PFE)

Business Focus: Pharmaceuticals

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEC Form 4 filings for PFE*US within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Dec 03, 2020 07:30 ET
Thinking about buying stock in Pfizer, China Automotive Systems, Omeros Corp, Nio, or FuelCell Energy?
NEW YORK, Dec. 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, CAAS, OMER, NIO, and FCEL....
Read full article
Dec 02, 2020 07:30 ET
Thinking about buying stock in Aurora Cannabis, Pfizer, Viveve Medical, NetApp, or iBio?
NEW YORK, Dec. 2, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, PFE, VIVE, NTAP, and IBIO....
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.70
--
--
Price to Sales - TTM
4.66
3.97
6.05
Price to Book - most recent quarter
3.47
2.82
3.58
Price to Cash Flow per share - TTM
16.79
12.97
16.86
Price to Free Cash Flow per share - TTM
113.59
24.79
26.80
See all valuations

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

See business summary

 

Twitter

Search (past week) for $PFE